Gateway Biotechnology Inc.

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
With a decade of product development funded by awards from the National Institutes of Health (NIH), Gateway Biotechnology has been developing drug candidates to combat hearing disorders. Our innovative approach, grounded in a deep understanding of basic mechanisms underlying hearing loss, targets multiple cellular pathways with new product formulations that fine-tune drug delivery to the ear. Our lead candidates demonstrate great efficacy in preventing and treating tinnitus.
Company Type:
Company Website:
Company HQ State:
Missouri
Company HQ Country:
United States
Year Founded:
2011
Main Therapeutic Focus:
Lead Product in Development:
Drug that treats tinnitus
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
Gateway Biotechnology, Inc.